As F. nucleatum is found in several cancer types (including Colon, esophageal, pancreatic and breast) it is plausible to hypothesize that CEACAM1 activation by tumor-colonized fusobacteria might suppress anti-tumor immunity and affect disease outcome. Here, CEACAM1 is linked to neoplasm.